Intravascular imaging technology developer Avinger plans to raise $4.5 million by making a public offering of 3.8 million of its common stock shares.
The company will use the proceeds of the sale for working capital, research and development of its Lumivascular image-guided atherectomy platform, preclinical and clinical trials, regulatory submissions, and sales and marketing efforts, it said.
Aegis Capital is running the offering, which is expected to close on August 26, according to Avinger.
